Yahoo Web Search

Search results

1. Top Stories

   • 

     Benzinga on MSN.com

     Why Is Mid-Cap Cancer-Focused Replimune Stock Trading Higher On Thursday?

     2 hours ago

   • Seeking Alpha

     Bristol-Myers: Why I Am Buying More Of This Falling Knife, Yielding 5.84%

     Bristol-Myers Squibb has experienced significant declines in its stock price, but I believe it has potential for future growth. Read more about BMY stock here.

     2 days ago

   • 

     YAHOO!Finance

     Here’s Why Jim Cramer Says You Should Not Buy Bristol-Myers Squibb Co (NYSE:BMY)

     1 day ago

   • Business Insider

     Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY) and Ionis Pharmaceuticals (IONS)

     Analysts have been eager to weigh in on the Healthcare sector with new ratings on Bristol-Myers Squibb (BMY – Research Report) and Ionis

     7 hours ago

   • YAHOO!Finance

     Shareholders in Bristol-Myers Squibb (NYSE:BMY) are in the red if they invested a year ago

     2 days ago

   View all

2. seekingalpha.com › article › 4697112-bristol-myersBristol-Myers: Why I Am Buying More Of This Falling Knife ...

   seekingalpha.com › article › 4697112-bristol-myers

   2 days ago · BMY's $52 strike price call option expiring in June 2025 would give you 6% dividend for the year, about 4% call premium, and if you lose the stock above $52 a capital gain of about 24%. The 5+4+24 ...

3. Bristol-Myers Squibb Company

   NYSE: BMY

   40.94

   Add to watchlist

   Sign in to add to watchlist

   Sign In

   -0.30 (-0.73%)

   As of Thu. Jun 6, 2024 2:30 PM EDT · Nasdaq Real Time Price (USD) · Market open

   Full chart

   • 1D
   • 5D
   • 1M
   • 6M
   • YTD
   • 1Y
   • MAX

   • Open	40.86
     High	41.29
     Low	40.70

   • Mkt Cap	82.99B
     P/E (TTM)	N/A
     Div & Yield	2.40 & 5.82%

   • Prev. Close	41.24
     52 Wk. Low	39.91
     52 Wk. High	66.38

   More about BMY

   What analysts are saying

   Morningstar Bullish Published May 23 · Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A... Read more

   Top stories

   • CELG-RT
   • BMY
     -0.73%

   Here’s Why Jim Cramer Says You Should Not Buy Bristol-Myers Squibb Co (NYSE:BMY)

   Yahoo Finance · 1 day ago

   

   • CELG-RT
   • BMY
     -0.73%

   Why Bristol Myers Squibb (BMY) Outpaced the Stock Market Today

   Yahoo Finance · 3 days ago

   

   • BMY
     -0.73%
   • CELG-RT

   Shareholders in Bristol-Myers Squibb (NYSE:BMY) are in the red if they invested a year ago

   Yahoo Finance · 2 days ago

   

   Related stocks

   • MRK
     Merck & Co., Inc.
     MRK
     129.79
     +0.26%
   • LLY
     Eli Lilly and Company
     LLY
     835.69
     +0.47%
   • ABT
     Abbott Laboratories
     ABT
     104.18
     +0.92%
   • ABBV
     AbbVie Inc.
     ABBV
     167.89
     +1.48%
   • AMGN
     Amgen Inc.
     AMGN
     305.01
     -0.77%

   More on Yahoo Finance

4. markets.businessinsider.com › news › stocksAnalysts Offer Insights on Healthcare Companies: Bristol ...

   markets.businessinsider.com › news › stocks

   • Cached

   18 hours ago · Bristol-Myers Squibb (BMY) TD Cowen analyst Steve Scala maintained a Hold rating on Bristol-Myers Squibb today and set a price target of $67.00 . The company’s shares closed last Wednesday at ...

5. www.marketbeat.com › stocks › NYSEBristol-Myers Squibb (BMY) Stock Price, News & Analysis

   www.marketbeat.com › stocks › NYSE

   • Cached

   1 day ago · Should You Buy or Sell Bristol-Myers Squibb Stock? Get The Latest BMY Stock Analysis, Price Target, Dividend Info, Headlines, and Short Interest at MarketBeat.

   • 5/5
   • Employees: 34K

   • Email: john.elicker@bms.com

6. People also ask

   Is BMY a good stock to buy?

   • BMY has enough on-hand liquidity to manage its short-term debt maturities, and after all the liabilities are accounted for, there is $16.55 billion in equity on the books. When it comes to the income and cash flow statements, I think investors are looking at the bottom line and getting worried.

   Bristol-Myers: Why I Am Buying More Of This Falling Knife, Yielding 5.84…

   seekingalpha.com/article/4697112-bristol-myers-why-i-am-buying-more-of-this-falling-knife-yielding-5-84-percent

   See all results for this question

   What are BMY share price targets?

   • Their BMY share price targets range from $43.00 to $85.00. On average, they anticipate the company's stock price to reach $60.00 in the next year. This suggests a possible upside of 46.0% from the stock's current price. View analysts price targets for BMY or view top-rated stocks among Wall Street analysts.

   Bristol-Myers Squibb (BMY) Stock Price, News & Analysis - MarketBeat

   www.marketbeat.com/stocks/NYSE/BMY/

   See all results for this question

   Should investors hold BMY shares?

   • The consensus among Wall Street equities research analysts is that investors should "hold" BMY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BMY, but not buy additional shares or sell existing shares. View BMY analyst ratings or view top-rated stocks.

   Bristol-Myers Squibb (BMY) Stock Price, News & Analysis - MarketBeat

   www.marketbeat.com/stocks/NYSE/BMY/

   See all results for this question

   Is BMY a good stock to buy in 2024?

   • BMY is in a strong cash position and should produce over $10 billion in FCF in 2024. Looking past 2024, BMY is trading at less than 7 times earnings and currently has a price-to-FCF multiple of 6.66x. I think that the recent drop is a long-term opportunity, and investors are getting paid almost 6% from the dividend to stick it out with BMY.

   Bristol-Myers: Why I Am Buying More Of This Falling Knife, Yielding 5.84…

   seekingalpha.com/article/4697112-bristol-myers-why-i-am-buying-more-of-this-falling-knife-yielding-5-84-percent

   See all results for this question

7. seekingalpha.com › symbol › BMYBristol-Myers Squibb Company (BMY) Stock Price, Quote, News ...

   seekingalpha.com › symbol › BMY

   • Cached

   3 days ago · A high-level overview of Bristol-Myers Squibb Company (BMY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

8. www.zacks.com › stock › researchWhat is the current Price Target and Forecast for Bristol ...

   www.zacks.com › stock › research

   • Cached

   2 days ago · Based on short-term price targets offered by 18 analysts, the average price target for Bristol Myers Squibb comes to $53.17. The forecasts range from a low of $37.00 to a high of $67.00.

9. stockanalysis.com › stocks › bmyBristol-Myers Squibb Company (BMY) Company ... - Stock Analysis

   stockanalysis.com › stocks › bmy

   • Cached

   3 days ago · Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases.

10. www.marketscreener.com › quote › stockBristol-Myers Squibb Company Stock (BMY) - Quote Nyse ...

    www.marketscreener.com › quote › stock

    • Cached

    5 days ago · Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research Platforms